FFTY Innovator IBD 50 ETF

No holdings information is available in our database.

FFTY Innovator IBD 50 ETF

Seeks to track, before fees and expenses, the IBD 50 Index. The Index is a weekly computer-generated stock index compiled and published by Investorís Business Daily that compiles and ranks what it considers to be the 50 leading growth companies that trade on U.S. securities exchanges. The Indexís initial universe is the approximately 7,000 equity securities that trade on U.S. stock exchanges, including ADRs. The initial universe is narrowed down by excluding those companies that do not meet certain baseline criteria. IBD then narrows the universe further by screening out securities with price actions IBD views as undesirable. IBD then scores the remaining securities on 11 factors: Earnings Per Share Rating; Relative Price Strength Rating; Sales Margin Return on Equity Rating; Accumulation Distribution Rating; Industry Group Relative Strength; Growth in Quarterly Earnings/Next Quarter Consensus Estimates; 3-to-5 Year Annual Growth Rate/Next Yearís Consensus Estimates; Quarterly Sales Growth/Next Quarter Consensus Estimates; Acceleration in Quarterly Sales or Earnings; Liquidity and Annual Return on Equity. Each security is given a score for each factor. Each securityís 11 factor scores are then aggregated to provide a composite score. The 50 securities with the highest score are included in the Index and weighted according to their score. The Index includes a formula to adopt a defensive approach upon the occurrence of certain market signals that indicate that the equities market may be in, or entering, a downturn. Upon the occurrence of any of four market signals, at the next Index reconstitution, the Index will take a cash position of 50%.

On November 15, 2017, the fund changed from an actively managed fund to a fund tracking an index. The index was designed to be a close approximation of the current investment strategy pursued by the Fundís investment sub-adviser.

$30.65  +0.23 (0.76%)
As of 05/16/2022 16:00:00 EST     IEX book   CBOE book


ETF Information
Sponsor:     Innovator Funds
Category1:  US Equity
Category2:  Broad Market
Category3:  Multi-cap
Morningstar category:  Mid-Cap Growth
Leverage factor:  1.00
Note: Uses downside hedging
Inception date:  04/08/2015
Index tracking method: Passive replication
Current yield:  0.33%
Historical average yield:  0.07%
Market cap:  $131,805,000
Average volume:  62,254
Fees:     0.8000%

Index Information
IBD 50 Index
Index symbol:  IBD50Index
Provider:   Investors Business Daily
Index weighting:   Composite scores
Index inception date:  04/30/2003
Backtesting data exists:   No
Number of holdings:  50
Strategy:  Multi-factor investing
Factors used to select securities:

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy